BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25107687)

  • 1. MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations.
    Tanyi M; Olasz J; Tanyi JL; Tóth L; Antal-Szalmás P; Ress Z; Bubán T; Palatka K; András C; Urbancsek H; Garami Z; Csuka O; Damjanovich L
    Eur J Surg Oncol; 2014 Nov; 40(11):1445-52. PubMed ID: 25107687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
    Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
    World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.
    Papp J; Kovacs ME; Olah E
    World J Gastroenterol; 2007 May; 13(19):2727-32. PubMed ID: 17569143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
    Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
    BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Our experience with the incidence of hereditary non-polyposis colorectal cancer].
    Tanyi M
    Magy Seb; 2009 Apr; 62(2):87-94. PubMed ID: 19386570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
    Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
    Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
    Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
    Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
    Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
    Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
    Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
    Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients.
    Russo A; Sala P; Alberici P; Gazzoli I; Radice P; Montefusco C; Torrini M; Mareni C; Fornasarig M; Santarosa M; Viel A; Benatti P; Pedroni M; de Leon MP; Lucci-Cordisco E; Genuardi M; Messerini L; Stigliano V; Cama A; Curia MC; de Lellis L; Signoroni S; Pierotti MA; Bertario L
    Tumori; 2009; 95(6):731-8. PubMed ID: 20210238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany.
    Lamberti C; Mangold E; Pagenstecher C; Jungck M; Schwering D; Bollmann M; Vogel J; Kindermann D; Nikorowitsch R; Friedrichs N; Schneider B; Houshdaran F; Schmidt-Wolf IG; Friedl W; Propping P; Sauerbruch T; Büttner R; Mathiak M
    Digestion; 2006; 74(1):58-67. PubMed ID: 17095871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer.
    Wolf B; Henglmueller S; Janschek E; Ilencikova D; Ludwig-Papst C; Bergmann M; Mannhalter C; Wrba F; Karner-Hanusch J
    Wien Klin Wochenschr; 2005 Apr; 117(7-8):269-77. PubMed ID: 15926618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.